Generate a tailored SOP for Dr. Alex Abramson. Improve your application with a focused, well-structured draft.
The Abramson Lab develops ingestible, implantable, and wearable robotic therapeutic devices to solve key healthcare problems and provide measurable therapeutic outcomes. The translationally focused research spans multiple areas, including drug delivery devices for optimal drug adherence, soft materials for bioelectronic sensors and therapeutics, and preclinical drug screening technologies. Alex Abramson's research emphasizes drug delivery and bioelectronic therapeutics and has been featured in news outlets such as the New York Times, NPR, and Wired. Recognized for his scientific innovation, he was named a member of Forbes' 30 Under 30 Science List and MIT Technology Review's Innovators 35 List. Dr. Abramson is also passionate about translating scientific endeavors from bench to bedside and has seen large pharmaceutical companies exclusively license a portfolio of patents for clinical trials, serving as a scientific advisor overseeing commercialization. Beyond his scientific work, he plays an active role in the community, leading diversity, equity, and inclusion efforts on campus and volunteering as a STEM tutor for local students.
Department of Computer Science: GRE scores are optional for Fall 2026.